New Market Report: ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis
ImmunoCellular Therapeutics, Ltd. (ImmunoCellular) is a clinical-stage biotechnology company. It undertakes the development of immune-based therapies to treat various types of cancers. The product pipeline of the company include active immunotherapies and patented monoclonal antibodies. The company's product candidate portfolio includes peptide based vaccine to target cancer stem cells; cellular immunotherapies targeting cancer antigens, cancer stem cell antigens; and monoclonal antibodies to diagnose and treat several different cancers including glioblastoma multiforme (GBM), small-cell lung cancer, pancreatic cancer and ovarian cancer.
View full press release